PDB Short entry for 2I93
HEADER                                            04-SEP-06   2I93              
TITLE     MODEL OF THE STRUCTURE OF THE START DOMAINS OF HUMAN                  
TITLE    2 STEROIDOGENIC ACUTE REGULATORY PROTEIN (STAR) IN COMPLEX             
TITLE    3 WITH CHOLESTEROL                                                     
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: STEROIDOGENIC ACUTE REGULATORY PROTEIN (STAR);             
COMPND   3 CHAIN: A;                                                            
COMPND   4 FRAGMENT: START DOMAIN (STARD1)                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   3 ORGANISM_COMMON: HUMAN                                               
KEYWDS    STEROIDOGENIC ACUTE REGULATORY PROTEIN, STAR, STAR-RELATED            
KEYWDS   2 LIPID TRANSFER, START, MLN64, CHOLESTEROL, DOCKING,                  
KEYWDS   3 HOMOLOGY MODELING, GENERALIZED-BORN, BINDING, MOLECULAR              
KEYWDS   4 DYNAMICS, CHOLESTEROL RELEASE                                        
EXPDTA    THEORETICAL MODEL                                                     
AUTHOR    M.MURCIA,J.D.FARALDO-GOMEZ,F.R.MAXFIELD,ROUX B.                       
REVDAT   3   05-DEC-06 2I93    1       JRNL                                     
REVDAT   2   24-OCT-06 2I93    1       JRNL                                     
REVDAT   1   19-SEP-06 2I93    0                                                
JRNL        AUTH   M.MURCIA,J.D.FARALDO-GOMEX,F.R.MAXFIELD,B.ROUX               
JRNL        TITL   MODELING THE STRUCTURE OF THE START DOMAINS OF               
JRNL        TITL 2 MLN64 AND STAR PROTEINS IN COMPLEX WITH                      
JRNL        TITL 3 CHOLESTEROL.                                                 
JRNL        REF    J.LIPID RES.                  V.  47  2614 2006              
JRNL        REFN   ASTM JLPRAW  US ISSN 0022-2275                               
REMARK   1                                                                      
REMARK   2                                                                      
REMARK   2 RESOLUTION. NOT APPLICABLE.                                          
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : CHARMM 31A0                                          
REMARK   3   AUTHORS     : BROOKS ET AL.                                        
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: A HOMOLOGY MODEL OF THE THREE-            
REMARK   3  DIMENSIONAL STRUCTURE OF HUMAN STAR-START IN COMPLEX WITH           
REMARK   3  CHOLESTEROL WAS BUILT WITH CHARMM USING THE MLN64-START             
REMARK   3  CRYSTAL STRUCTURE AS A TEMPLATE (PDB ID : 1EM2), BASED ON A         
REMARK   3  PAIR-WISE SEQUENCE ALIGNMENT PRODUCED WITH CLUSTALW. THE            
REMARK   3  IDENTITY OF BOTH SEQUENCES IS 36%, WITH NO INSERTIONS OR            
REMARK   3  DELETIONS. THE COORDINATES OF ALL BACKBONE ATOMS AS WELL AS         
REMARK   3  THOSE OF CONSERVED OR STRUCTURALLY SIMILAR SIDE CHAINS (E.G.        
REMARK   3  ASP AND ASN) WERE PRESERVED FROM THE TEMPLATE. OTHERWISE, NEW       
REMARK   3  COORDINATES WERE ASSIGNED USING SCWRL 3.0, AND SUBSEQUENTLY         
REMARK   3  ENERGY-MINIMIZED. A CHOLESTEROL MOLECULE IN THE PREFERRED           
REMARK   3  BINDING MODE IN MLN64-START (SEE THE CORRESPONDING MODEIL) WAS      
REMARK   3  INCLUDED WHILE BUILDING THE MODEL. THE THREE-DIMENSIONAL MODEL      
REMARK   3  OF THE ATOMIC STRUCTURE OF STAR-START IN COMPLEX WITH               
REMARK   3  CHOLESTEROL WAS FINALLY ANALYZED THROUGH MD SIMULATIONS (10         
REMARK   3  INDEPENDENT RUNS OF 1.5 NS EACH). ALL MD SIMULATIONS WERE           
REMARK   3  PERFORMED USING VERSION C31A0 OF THE CHARMM BIOMOLECULAR            
REMARK   3  SIMULATION SOFTWARE ALONGSIDE THE CHARMM22/CMAP ALL-ATOM            
REMARK   3  PROTEIN FORCE FIELD. AN IMPLICIT MODEL OF THE SOLVENT WAS USED      
REMARK   3  IN ALL SIMULATIONS, AS IMPLEMENTED IN THE GBSW MODULE OF            
REMARK   3  CHARMM.                                                             
REMARK   4                                                                      
REMARK   4 2I93 COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998                       
REMARK 100                                                                      
REMARK 100 THIS ENTRY WAS DEPOSITED AT RCSB ON 04-SEP-2006.                     
REMARK 100 THE RCSB ID CODE IS RCSB039291.                                      
REMARK 220                                                                      
REMARK 220 EXPERIMENTAL DETAILS                                                 
REMARK 220  EXPERIMENT TYPE                : THEORETICAL MODELLING              
REMARK 220                                                                      
REMARK 220 REMARK: 10 THEORETICAL MODELS TAKEN FROM THE 10 LAST                 
REMARK 220         CONFIGURATIONS OF 10 INDEPENDENT MD SIMULATIONS OF 1.5       
REMARK 220         NS EACH. THIS THEORETICAL MODEL ENTRY WAS NOT ANNOTATED      
REMARK 220         AND NOT VALIDATED BY THE WWPDB STAFF AND THEREFORE MAY       
REMARK 220         NOT CONFORM TO THE PDB FORMAT.                               
REMARK 225                                                                      
REMARK 225 THEORETICAL MODEL                                                    
REMARK 225 THE COORDINATES IN THIS ENTRY REPRESENT A MODEL STRUCTURE.           
REMARK 225 PROTEIN DATA BANK CONVENTIONS REQUIRE THAT CRYST1 AND                
REMARK 225 SCALE RECORDS BE INCLUDED, BUT THE VALUES ON THESE                   
REMARK 225 RECORDS ARE MEANINGLESS.                                             
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 1EM2   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF THE APO FORM OF THE START DOMAIN OF             
REMARK 900 MLN64                                                                
REMARK 900 RELATED ID: 1JSS   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF THE APO FORM OF THE START DOMAIN OF             
REMARK 900 STARD4                                                               
REMARK 900 RELATED ID: 1LN1-3   RELATED DB: PDB                                 
REMARK 900 CRYSTAL STRUCTURES OF THE BOUND FORM OF THE START DOMAIN OF          
REMARK 900 PCTP IN COMPLEX WITH PC                                              
REMARK 900 RELATED ID: 1IMG   RELATED DB: PDB                                   
REMARK 900 THEORETICAL MODEL OF THE START DOMAIN OF STAR (HUMAN)                
REMARK 900 RELATED ID: 1ILJ   RELATED DB: PDB                                   
REMARK 900 THEORETICAL MODEL OF THE START DOMAIN OF STAR (HAMSTER)              
REMARK 900 RELATED ID: PENDING   RELATED DB: PDB                                
REMARK 900 THEORETICAL MODEL OF THE START DOMAIN OF MLN64 (HUMAN) IN            
REMARK 900 COMPLEX WITH CHOLESTEROL (MURCIA ET AL.) THE CHOLESTEROL             
REMARK 900 ORIENTATION OF THIS MODEL IS USED AS A TEMPLATE WHEN                 
REMARK 900 BUILDING STAR'S MODEL                                                
SEQRES   1 A  214  LEU TYR SER ASP GLN GLU LEU ALA TYR LEU GLN GLN GLY          
SEQRES   2 A  214  GLU GLU ALA MET GLN LYS ALA LEU GLY ILE LEU SER ASN          
SEQRES   3 A  214  GLN GLU GLY TRP LYS LYS GLU SER GLN GLN ASP ASN GLY          
SEQRES   4 A  214  ASP LYS VAL MET SER LYS VAL VAL PRO ASP VAL GLY LYS          
SEQRES   5 A  214  VAL PHE ARG LEU GLU VAL VAL VAL ASP GLN PRO MET GLU          
SEQRES   6 A  214  ARG LEU TYR GLU GLU LEU VAL GLU ARG MET GLU ALA MET          
SEQRES   7 A  214  GLY GLU TRP ASN PRO ASN VAL LYS GLU ILE LYS VAL LEU          
SEQRES   8 A  214  GLN LYS ILE GLY LYS ASP THR PHE ILE THR HIS GLU LEU          
SEQRES   9 A  214  ALA ALA GLU ALA ALA GLY ASN LEU VAL GLY PRO ARG ASP          
SEQRES  10 A  214  PHE VAL SER VAL ARG CYS ALA LYS ARG ARG GLY SER THR          
SEQRES  11 A  214  CYS VAL LEU ALA GLY MET ASP THR ASP PHE GLY ASN MET          
SEQRES  12 A  214  PRO GLU GLN LYS GLY VAL ILE ARG ALA GLU HIS GLY PRO          
SEQRES  13 A  214  THR CYS MET VAL LEU HIS PRO LEU ALA GLY SER PRO SER          
SEQRES  14 A  214  LYS THR LYS LEU THR TRP LEU LEU SER ILE ASP LEU LYS          
SEQRES  15 A  214  GLY TRP LEU PRO LYS SER ILE ILE ASN GLN VAL LEU SER          
SEQRES  16 A  214  GLN THR GLN VAL ASP PHE ALA ASN HIS LEU ARG LYS ARG          
SEQRES  17 A  214  LEU GLU SER HIS PRO ALA                                      
HET    CLR  A   1      74                                                       
HETNAM     CLR CHOLESTEROL                                                      
FORMUL   2  CLR    C27 H46 O                                                    
HELIX    1   1 SER A   69  SER A   91  1                                  23    
HELIX    2   2 PRO A  129  GLU A  139  1                                  11    
HELIX    3   3 GLU A  142  TRP A  147  5                                   6    
HELIX    4   4 ALA A  231  SER A  233  5                                   3    
HELIX    5   5 PRO A  252  HIS A  278  1                                  27    
SHEET    1   A 9 LYS A  97  GLN A 101  0                                        
SHEET    2   A 9 LYS A 107  VAL A 113 -1  O  VAL A 108   N  SER A 100           
SHEET    3   A 9 GLY A 117  VAL A 126 -1  O  VAL A 119   N  LYS A 111           
SHEET    4   A 9 THR A 237  LEU A 243 -1  O  THR A 237   N  VAL A 126           
SHEET    5   A 9 THR A 223  PRO A 229 -1  N  HIS A 228   O  LYS A 238           
SHEET    6   A 9 CYS A 197  ASP A 203 -1  N  GLY A 201   O  THR A 223           
SHEET    7   A 9 ARG A 182  ARG A 192 -1  N  VAL A 187   O  MET A 202           
SHEET    8   A 9 THR A 164  ALA A 171 -1  N  GLU A 169   O  PHE A 184           
SHEET    9   A 9 VAL A 151  ILE A 160 -1  N  LYS A 152   O  LEU A 170           
SHEET    1   B 8 LYS A  97  GLN A 101  0                                        
SHEET    2   B 8 LYS A 107  VAL A 113 -1  O  VAL A 108   N  SER A 100           
SHEET    3   B 8 GLY A 117  VAL A 126 -1  O  VAL A 119   N  LYS A 111           
SHEET    4   B 8 THR A 237  LEU A 243 -1  O  THR A 237   N  VAL A 126           
SHEET    5   B 8 THR A 223  PRO A 229 -1  N  HIS A 228   O  LYS A 238           
SHEET    6   B 8 CYS A 197  ASP A 203 -1  N  GLY A 201   O  THR A 223           
SHEET    7   B 8 ARG A 182  ARG A 192 -1  N  VAL A 187   O  MET A 202           
SHEET    8   B 8 ILE A 216  ARG A 217  1  O  ILE A 216   N  ASP A 183           
CRYST1    1.000    1.000    1.000  90.00  90.00  90.00 P 1           1          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      1.000000  0.000000  0.000000        0.00000                         
SCALE2      0.000000  1.000000  0.000000        0.00000                         
SCALE3      0.000000  0.000000  1.000000        0.00000